Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer

M Chen, L Cai, Y Xiang, L Zhong, J Shi - Bioorganic Chemistry, 2023 - Elsevier
Most patients with advanced prostate cancer (PCa) will develop metastatic castration-
resistant prostate cancer (mCRPC) after androgen deprivation therapy, at this time the tumor …
被引用次数：8 相关文章

Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer

M Chen, L Cai, Y Xiang, L Zhong, J Shi - Bioorganic chemistry - pubmed.ncbi.nlm.nih.gov
Most patients with advanced prostate cancer (PCa) will develop metastatic castration-
resistant prostate cancer (mCRPC) after androgen deprivation therapy, at this time the tumor …

Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer.

M Chen, L Cai, Y Xiang, L Zhong, J Shi - Bioorganic Chemistry, 2023 - europepmc.org
Most patients with advanced prostate cancer (PCa) will develop metastatic castration-
resistant prostate cancer (mCRPC) after androgen deprivation therapy, at this time the tumor …